Navigation Links
ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
Date:4/8/2010

ClearTrial software brings dramatic efficiency gains to clinical operations and outsourcing for biopharmaceutical and medical device companies.

Chicago, IL (PRWEB) April 8, 2010 -- ClearTrial (www.cleartrial.com), the leading provider of Clinical Trial Operations (CTO) software, today announced that it will be demonstrating the software's capabilities to drive greater efficiency in clinical operations and outsourcing to an audience of more than 1,800 industry professionals at the 19th Annual Partnerships in Clinical Trials conference. The event attracts clinical operations, outsourcing, project management and business development executives from trial sponsors and Clinical Research Organizations (CROs), who come together to further their industry partnerships and to share ideas on maximizing the return on investment for every clinical research dollar spent.

"Conference attendees will see firsthand how ClearTrial software delivers efficiency gains such as the -1% cost variance on a $130 million clinical trial portfolio achieved by one Top 20 sponsor," noted ClearTrial CEO Mike Soenen. "The company used the ClearTrial software, with its embedded industry intelligence and activity-based costing architecture, to generate independent cost, resource, and timeline forecasts -- achieving better cost control and adding speed and accuracy to clinical operations and outsourcing."

During the conference, attendees can also learn how companies are leveraging ClearTrial software to gain the benefits of:

 
  • Strategic collaboration
  • Streamlined negotiations and contract closure
  • Fast, easy creation of detailed RFPs
  • Reduction in change orders and quick reforecasting
  • Fast and accurate cost accruals
  • Improved project status tracking
  • Cash-neutral payment schedules

At ClearTrial booth #543, scheduled demos of the ClearTrial software will take place at the following dates and times:

Monday, April 12
5:30 p.m. (during the Grand Opening Reception)

Tuesday, April 13
11:00 a.m.
1:00 p.m.
3:30 p.m.

Wednesday, April 14
10:30 a.m.
1:30 p.m.

The Partnerships in Clinical Trials 2010 event will be held at the Orlando World Center Marriott Resort in Orlando, Florida on April 12-14. For more information and to register for the conference, visit http://www.iirusa.com/cropartners/welcome-to-CROs.xml.

About ClearTrial®
ClearTrial is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial’s award-winning software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company’s software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

For more information contact:
Mike Lange
ClearTrial
+1 630.986.9800 x112

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3849454.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
2. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
3. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
4. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
5. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
6. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
7. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
8. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
9. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
10. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
11. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2017)... ... February 25, 2017 , ... The ... in an ongoing effort to create meaningful change by increasing communication, partnerships and ... emphasis on consumers and patients’ mental health well-being. , Both organizations are dedicated ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  Aethlon Medical, ... following note authored by its Chairman and CEO, ... at the Munich Security Conference last Saturday, Bill ... virus could kill more people than nuclear weapons. Mr. ... U.S. and U.K. intelligence agencies, that scientific terrorists have ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
Breaking Biology Technology:
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
Breaking Biology News(10 mins):